Vnitr Lek 2018, 64(3):227-228 | DOI: 10.36290/vnl.2018.031
Choroby asociované s imunoglobulinem IgG4 - editorial
- Ústav klinické imunologie a alergologie LF UK a FN Hradec Králové
Received: September 11, 2017; Published: March 1, 2018 Show citation
References
- Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol 2017; 13(9): 867-875. Dostupné z DOI: <http://dx.doi.org/10.1080/1744666X.2017.1354698>.
Go to original source...
Go to PubMed...
- Frampton JE. Ocrelizumab: First global approval. Drugs 2017; 77(9): 1035-1041. Dostupné z DOI: <http://dx.doi.org/10.1007/s40265-017-0757-6>.
Go to original source...
Go to PubMed...
- Kawa S, Skold M, Ramsden DB et al. Serum IgG4 concentration in IgG4-related disease. Clin Lab 2017; 63(9): 1323-1337. Dostupné z DOI: <http://dx.doi.org/10.7754/Clin.Lab.2017.170403>.
Go to original source...
Go to PubMed...
- Trampert DC, Hubers LM, van de Graaf SFJ et al. On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. Biochim Biophys Acta 2017. pii: S0925-4439(17)30273-9. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bbadis.2017.07.038>.
Go to original source...
Go to PubMed...
- Yadlapati S, Verheyen E, Efthimiou P. IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 2018; 38(2): 169-177. Dostupné z DOI: <http://dx.doi.org/10.1007/s00296-017-3765-7>.
Go to original source...
Go to PubMed...
- Krejsek J, Andrýs C, Krčmová I. Imunologie člověka. Garamon: Hradec Králové 2016. ISBN 978-80-86472-74-4.